[1] FriedmanSL .Hepaticfibrosis.[M ]In:SchiffER , SorrellMF , MddreyWC .Schiff’sDiseaseoftheLiver.8thed.Philadelphia:Lippincott-Raven, 1999.371-386.
|
[2] 程明亮, 刘三都肝纤维化基础和临床[M ].北京:人民出版社, 1996228-290.
|
[3] 车建途治疗肝纤维化的药物[J].中华消化杂志, 1993, 11∶50-51.
|
[4]马学惠丹参对实验性肝硬化细胞外基质影响的免疫组化观察[J].肝脏病学杂志, 1994, 2∶79-801.
|
[1] | Peng ZHANG, Shihao ZHENG, Siyuan GOU, Jinchi XIE, Xianzhao YANG, Yongan YE. The mechanism of compound traditional Chinese medicine prescriptions in reversal of liver fibrosis and early liver cirrhosis[J]. Journal of Clinical Hepatology, 2024, 40(9): 1873-1879. doi: 10.12449/JCH240924 |
[2] | Ting LI, Huabao LIU, Wenyan HU, Chunyan RAO. Role of inflammation in hepatic fibrosis[J]. Journal of Clinical Hepatology, 2022, 38(10): 2368-2372. doi: 10.3969/j.issn.1001-5256.2022.10.032 |
[3] | Chen XiaoQian, Zhang Feng, Wang ZhiYu, Cai YanJun, Qi Yue. Colchicine-induced liver injury with autoimmune features: a case report[J]. Journal of Clinical Hepatology, 2018, 34(2): 383-386. doi: 10.3969/j.issn.1001-5256.2018.02.034 |
[4] | Suo HaiFen, Zhu YaoJu. Effect of sophocarpidine and diammonium glycyrrhizinate injection on hepatic fibrosis and the content of interferon-γ of chronicity type B Hepatitis patients[J]. Journal of Clinical Hepatology, 2010, 26(2): 196-198. |
[5] | Jiang ZhongSheng, Wen XiaoFeng, Ke Liu, Tan Chuan, Chen Nian, Li MinJi. The diagnostic value of APRI and Forns index for liver fibrosis of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(6): 423-425. |
[6] | Qin Gang, Shi GuangFeng, Li Qian, Lu Qing, Chen Shu. Inhibitory effects of UDCA on porcine serum-induced rat liver fibrosis[J]. Journal of Clinical Hepatology, 2007, 23(4): 263-265. |
[7] | Zhang Wei, Chen Ming, Cui Tao. Therapeutical and preventative effect of β-carotene on hepatic fibrosis in mice[J]. Journal of Clinical Hepatology, 2007, 23(4): 260-262. |
[8] | Xia Qi, Fu JieHai, Cai WeiMin, Liu RongHua. Diagnostic value of AST/PLT and GGT/PLT for hepatic fibrosis.[J]. Journal of Clinical Hepatology, 2007, 23(5): 364-366. |
[11] | Peng AnBang, Yao YuHong, Xie LiMing, Qian Xian. Clinial efficacy of kwoninone in the treatment hepatic fibrosis with hepatitis B virus[J]. Journal of Clinical Hepatology, 2004, 20(5): 279-280. |
[12] | Zhao CaiYan, Liu JingWen, Liang BaoLi, Li JianMei. Relationship between serum leptin and liver fibrosis in patients with alcoholic liver disease[J]. Journal of Clinical Hepatology, 2004, 20(6): 348-350. |
[13] | Zhen YanBo, Liu XiaoHua, Zhao Ping. Influence of matrine on serum levels of IL-6, IL-8 in patients with liver fibrosis induced by chronic hepatitis B.[J]. Journal of Clinical Hepatology, 2004, 20(2): 87-88. |
[14] | Chu YanJun, Lu YanRu. Effects of spirulina in prevention of liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2003, 19(6): 372-373. |
[16] | Kong Li, Li BingShun, Ren ZhongXuan, Hu YunLong, Liu JinXing. The study of inhibitory effect of IFN-α therapy for hepatic fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2002, 18(6): 356-358. |
[17] | Zhang ChunLan, Shi YaLing. The Relation of Hepatic Fibrosis Indexes to HBVDNA Title and Pathological Change[J]. Journal of Clinical Hepatology, 2000, 16(4): 220-221. |